Data analysis shows convalescent plasma improves survival in COVID-19 patients with blood cancers
February 11, 2021
Media contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 11, 2021) — Treatment with convalescent plasma was associated with significant survival benefit in patients with blood cancer who were hospitalized with COVID-19. The new data analysis was released Feb. 5 by the COVID-19 and Cancer Consortium (CCC19). The Mays Cancer Center, home to UT […]